Innate immune signalling at intestinal mucosal surfaces: a fine line between host protection and destruction

被引:50
作者
Cario, Elke [1 ,2 ]
机构
[1] Univ Hosp Essen, Div Gastroenterol & Hepatol, Inst Grp, D-45147 Essen, Germany
[2] Univ Duisburg Essen, Sch Med, Essen, Germany
关键词
host defense; inflammatory bowel disease; immune tolerance; intestinal epithelial cell; intestinal microflora; nuclear factor kappa B; nucleotide-binding oligomerization domain-1-like receptors; pattern recognition; Th17; Toll-like receptors;
D O I
10.1097/MOG.0b013e32830c4341
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose of review Emerging evidence underscores that inappropriate innate immune responses driven by commensals contribute to the pathogenesis of chronic inflammatory bowel diseases in genetically susceptible hosts. The present review focuses on defining the recently described mechanistic functions through which the innate immune signalling apparatus shapes mucosal homeostasis of the intestine in health and disease. Recent findings Commensal-induced innate immune signalling actively drives at least six major interdependent functions to control homeostasis in the healthy intestinal mucosa: 1) barrier preservation, 2) inhibition of apoptosis and inflammation, 3) acceleration of wound repair and tissue regeneration, 4) exclusion of harmful pathogens through autophagy and other antimicrobial defenses, while 5) maintaining immune tolerance towards harmless commensals, and 6) linkage to adaptive immunity. Any disturbance of this peaceful and mutually beneficial host-commensal relationship may imbalance innate immune signalling, which predisposes to chronic intestinal inflammation and associated tumourigenesis in inflammatory bowel diseases. Summary Recent advances have highlighted the complex mechanistics and functional diversity of innate immunity that paradoxically mediate both protective and destructive responses in the intestinal mucosa. Related signalling targets may offer novel therapeutic approaches in the treatment of inflammatory bowel diseases and inflammation-related cancer.
引用
收藏
页码:725 / 732
页数:8
相关论文
共 71 条
  • [1] Birchler T, 2001, EUR J IMMUNOL, V31, P3131, DOI 10.1002/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO
  • [2] 2-G
  • [3] An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models
    Burdelya, Lyudmila G.
    Krivokrysenko, Vadim I.
    Tallant, Thomas C.
    Strom, Evguenia
    Gleiberman, Anatoly S.
    Gupta, Damodar
    Kurnasov, Oleg V.
    Fort, Farrel L.
    Osterman, Andrei L.
    DiDonato, Joseph A.
    Feinstein, Elena
    Gudkov, Andrei V.
    [J]. SCIENCE, 2008, 320 (5873) : 226 - 230
  • [4] Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium
    Cario, E
    Brown, D
    McKee, M
    Lynch-Devaney, K
    Gerken, G
    Podolsky, DK
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (01) : 165 - 173
  • [5] Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C
    Cario, E
    Gerken, G
    Podolsky, DK
    [J]. GASTROENTEROLOGY, 2004, 127 (01) : 224 - 238
  • [6] Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function
    Cario, E.
    Gerken, G.
    Podolsky, D. K.
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : 1359 - 1374
  • [7] Trypsin-sensitive modulation of intestinal epithelial MD-2 as mechanism of lipopolysaccharide tolerance
    Cario, Elke
    Golenbock, Douglas T.
    Visintin, Alberto
    Ruenzi, Michael
    Gerken, Guido
    Podolsky, Daniel K.
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 (07) : 4258 - 4266
  • [8] Negative regulation of Toll-like receptor signaling by NF-κB p50 ubiquitination blockade
    Carmody, Ruaidhri J.
    Ruan, Qingguo
    Palmer, Scott
    Hilliard, Brendan
    Chen, Youhai H.
    [J]. SCIENCE, 2007, 317 (5838) : 675 - 678
  • [9] Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-κB activation
    Chang, YJ
    Wu, MS
    Lin, JT
    Sheu, BS
    Muta, T
    Inoue, H
    Chen, CC
    [J]. MOLECULAR PHARMACOLOGY, 2004, 66 (06) : 1465 - 1477
  • [10] The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases
    De Jager, P. L.
    Franchimont, D.
    Waliszewska, A.
    Bitton, A.
    Cohen, A.
    Langelier, D.
    Belaiche, J.
    Vermeire, S.
    Farwell, L.
    Goris, A.
    Libioulle, C.
    Jani, N.
    Dassopoulos, T.
    Bromfield, G. P.
    Dubois, B.
    Cho, J. H.
    Brant, S. R.
    Duerr, R. H.
    Yang, H.
    Rotter, J. I.
    Silverberg, M. S.
    Steinhart, A. H.
    Daly, M. J.
    Podolsky, D. K.
    Louis, E.
    Hafler, D. A.
    Rioux, J. D.
    [J]. GENES AND IMMUNITY, 2007, 8 (05) : 387 - 397